Par Health USA recalls

Par Health USA has 4 recalls on record with the FDA and USDA, the earliest in 2026 and the latest reported on 28 Oct 2026. 4 are still ongoing. 4 were reported in the last 12 months.

Total recalls4since 2026
Last 12 months4reported
Class I250% of total
Ongoing4latest 28 Oct 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 2 50%Class II 2 50%Class III 0 0%

Why par health usa is recalled

Product types

By year

Ongoing par health usa recalls

4 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IArgatroban Injection, USP, 250 mg/ (100 mg/mL) x Dose Vial recalledArgatrobanPar Health USAParticulate MatterNationwide
DrugCLASS IArgatroban Injection, USP, 250 mg/ (100 mg/mL) x Dose Vial recalledArgatrobanPar Health USAParticulate MatterNationwide
DrugCLASS IIBuprenorphine Hydrochloride, Injection 0.3 mg/mL recalledBuprenorphine HydrochloridePar Health USAOtherNationwide
DrugCLASS IIBuprenorphine HCl, CIII, Injection, 0.3 mg/mL recalled by Par Health USABuprenorphine HydrochloridePar Health USAOtherNationwide

All par health usa recalls, newest first

4 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IArgatroban Injection, USP, 250 mg/ (100 mg/mL) x Dose Vial recalledArgatrobanPar Health USAParticulate MatterNationwide
DrugCLASS IArgatroban Injection, USP, 250 mg/ (100 mg/mL) x Dose Vial recalledArgatrobanPar Health USAParticulate MatterNationwide
DrugCLASS IIBuprenorphine Hydrochloride, Injection 0.3 mg/mL recalledBuprenorphine HydrochloridePar Health USAOtherNationwide
DrugCLASS IIBuprenorphine HCl, CIII, Injection, 0.3 mg/mL recalled by Par Health USABuprenorphine HydrochloridePar Health USAOtherNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.